|View printer-friendly version|
|July 01, 2007 1:51 p.m.|
|Teva Announces Approval Of Amlodipine Besylate Tablets|
Jerusalem, Israel, July 1, 2007 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration (FDA) has granted approval for the company's ANDA for Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg. Shipment of the product will begin shortly.